
(AGENPARL) – SILVER SPRING lun 03 aprile 2023 This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have been subsequently withdrawn, and are therefore, no longer FDA-approved.
Fonte/Source: http://www.fda.gov/drugs/resources-information-approved-drugs/withdrawn-cancer-accelerated-approvals